Humana plans to mail more than 1 million in-home, preventive-screening kits to members in 2020, helping increase access to routine screenings that many members have put off during the pandemic, the company said in a press release.
Humana’s new initiative, which triples the number of screening kits sent to members, comes as many people have postponed all but the most necessary health procedures during COVID-19, limiting doctors’ appointments and emergency room visits.
“Because of the pandemic, many of our members – who are primarily seniors – have not been comfortable leaving their homes for routine health care,” said William Shrank, MD., Chief Medical Officer at Humana.
Humana’s push to deliver in-home tests will focus particularly on members in need of colorectal cancer screening and diabetic condition management. They are being provided at no additional cost to Medicare Advantage members who are eligible for the test.
In addition, eligible Medicaid members will receive the diabetic management test kits. This latest effort, which runs from June to September, builds on the company’s commitment to proactively mail easy-to-use colorectal cancer screening and diabetic management kits to qualifying members’ homes to identify cases of colon cancer earlier or to assess a patient's diabetes management to tailor therapy and help reduce complications of the disease.
